CT Laser Mammography Clinical Results Improves Mammography Sensitivity Highlighted at European Congress of Radiology (ECR).Study Results Compared CTLM CTLM Imaging Computed tomography laser mammography A diagnostic technique using lasers to produce a 3-D cross-sectional image of the breast without x-rays. See Mammography. to Mammography When Used Adjunctively for Detecting Angiogenesis in Women with Dense Breasts FORT LAUDERDALE, Fla. -- Imaging Diagnostic Systems, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :IMDS IMDS International Material Data System (automotive) IMDS Integrated Maintenance Data System IMDS Image Data Stream (Format) IMDS Integrated Mechanical Diagnostics System ), a pioneer in laser optical breast imaging systems, exhibited CT Laser Mammography (CTLM[R]) clinical results at the annual European Congress of Radiology European Congress of Radiology (ECR) Founded in 1967, the European Congress of Radiology was first held every four years in different locations. However, the idea of developing a new type of congress became more intensively discussed as the quadrennial basis and the ever (ECR 2009), March 6-10, in Vienna, Austria. IDSI is located at Expo 574. The clinical study accepted as one of the conferences' presentations was from the Tianjin Medical University Tianjin Medical University(TMU) founded in 1951 was the first medical institution approved by the State Council of the People’s Republic of China. Dr. Hsien-I Chu, a renowned endocrinologist, was the first president of the university. At present, Mr. Cancer Institute and Hospital, Tianjin, China. The study demonstrated that: "when the CTLM system was used as an adjunct to mammography in heterogeneously and extremely dense breasts, the sensitivity (detecting cancer) increased significantly." See company website for details of the published clinical report. One of the largest medical meetings in Europe and the second-largest radiology meeting in the world, ECR 2009 is expected to attract an estimated 18,000 participants worldwide. About Imaging Diagnostic Systems, Inc. Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM[R] system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM([R])) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis, which usually accompanies tumor growth. The company is currently undergoing the clinical studies required for the Premarket approval application. The FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. has determined that the Company's clinical study is a non-significant risk (NSR NSR abbr. normal sinus rhythm NSR Normal sinus rhythm, see there ) investigational device study under 812.3(m) of the investigational device exemptions (IDE) regulation (21 CFR CFR See: Cost and Freight 812). The CTLM system is limited by United States Federal Law to investigational use only in the United States. For more information, visit our website: www.imds.com As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion